Tag: gastrointestinal bleeding treatment devices industry size

  • Gastrointestinal Bleeding Treatment Devices Market Forecast Reveals Where Future Industry Value Will Be Created

    Gastrointestinal Bleeding Treatment Devices Market Forecast Reveals Where Future Industry Value Will Be Created

    Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

    The market for gastrointestinal bleeding treatment devices is experiencing steady growth, fueled by advances in technology and increasing demand for effective treatment options. As the prevalence of gastrointestinal disorders rises worldwide, this sector is positioned for expansion, with innovations and clinical needs driving further development. Let’s explore the market size, growth factors, key segments, and competitive landscape shaping this industry.

    Gastrointestinal Bleeding Treatment Devices Market Size and Growth Forecast

    The gastrointestinal bleeding treatment devices market has witnessed notable expansion recently. It is projected to increase from $0.92 billion in 2025 to $1 billion in 2026, marking a compound annual growth rate (CAGR) of 8.7%. Historical growth has been driven by rising instances of gastrointestinal disorders, increased prevalence of peptic ulcer disease, the expanding use of endoscopic diagnostic procedures, more hospital-based gastrointestinal interventions, and greater availability of advanced endoscopy equipment. Looking ahead, the market is expected to reach $1.39 billion by 2030, growing at a CAGR of 8.6%. This forecast is supported by the adoption of next-generation endoscopic devices, growing demand for outpatient gastrointestinal procedures, heightened focus on early bleeding detection, the rise of ambulatory surgical centers, and increased investments in advanced gastrointestinal care technologies. Key trends expected to influence growth include greater use of advanced endoscopic hemostasis devices, minimally invasive treatment methods, precision thermal ablation tools, expanding mechanical hemostatic solutions, and a strong emphasis on rapid bleeding control.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp

    Factors Contributing to the Rising Demand in the Gastrointestinal Bleeding Treatment Devices Market

    One of the main reasons behind the market’s lucrative prospects is the growing burden of gastrointestinal disorders globally. Conditions affecting the digestive system are often linked to factors such as low fiber intake, high stress, insufficient water consumption, excessive dairy intake, sedentary lifestyles, aging, and genetic predispositions. For example, a report released in October 2024 by the US National Library of Medicine highlighted that in 2023, 825 per 100,000 Canadians were diagnosed with inflammatory bowel disease (IBD), affecting over 320,000 people. Projections suggest this number could rise to around 470,000 individuals, or 1.1% of the population, by 2035. This increase in gastrointestinal disease prevalence is a key driver for growth in the gastrointestinal bleeding treatment devices sector.

    Detailed Segment Breakdown of the Gastrointestinal Bleeding Treatment Devices Market

    This market is categorized into several segments based on product type, gastrointestinal tract division, and end user. By product, the market includes Endoscopic Thermal Hemostasis Devices, Mechanical Hemostasis Devices, Injection-Based Hemostasis Devices, Topical Hemostatic Agents and Powders, and Combination or Multimodal Hemostasis Devices. Regarding the GI tract division, the market is split into Upper GI Tract and Lower GI Tract. End users primarily consist of Hospitals or Clinics, Ambulatory Surgical Centers, and other relevant facilities. Further subcategories delve into specific device types, such as Electrocautery and Electrosurgical Coagulation Devices, Argon Plasma Coagulation Devices, Hemostatic Clips, Endoscopic Band Ligation Devices, Epinephrine Injection Systems, Hemostatic Powder Sprays, and integrated multimodal endoscopic platforms, among others.

    Access The Complete Gastrointestinal Bleeding Treatment Devices Market Report:

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

    Innovations and Strategic Developments Defining Market Growth

    Leading companies in this sector are focusing on creating advanced solutions to improve treatment outcomes. One prominent example is Hemospray, a hemostatic powder designed to control active gastrointestinal bleeding during endoscopic procedures. Notably, in January 2024, AIG Hospitals in India introduced Hemospray as a breakthrough technology for managing GI bleeding. Its ease of use, safety, and effectiveness in controlling a wide range of GI bleeds—from peptic ulcers to variceal hemorrhages—make it a significant advancement in the field.

    Key Players and Competitive Landscape in the Gastrointestinal Bleeding Treatment Devices Market

    The industry features several major players driving innovation and market penetration. These include CONMED Corporation, Boston Scientific Corporation, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris plc, Medtronic plc, Johnson & Johnson, Abbott Laboratories, Fujifilm Holdings Corporation, Pentax Medical, Merit Medical Systems, Teleflex Incorporated, AngioDynamics, BTG International Ltd., Smiths Medical, Terumo Corporation, Nipro Corporation, C. R. Bard Inc., EndoChoice Holdings Inc., GI Supply Inc., and Hemostasis LLC.

    Regional Market Insights Highlighting Areas of Opportunity

    In 2025, North America held the largest share of the gastrointestinal bleeding treatment devices market. However, the Asia-Pacific region is anticipated to exhibit the fastest growth rate during the forecast period. The market coverage extends across Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive view of global market dynamics and future prospects.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Gastrointestinal Bleeding Treatment Devices Market Forecast Covering Industry Demand And Market Evolution

    Gastrointestinal Bleeding Treatment Devices Market Forecast Covering Industry Demand And Market Evolution

    The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

    What Market Value Expansion Is Expected For The Gastrointestinal Bleeding Treatment Devices Market Over The Forecast Period?

    The gastrointestinal bleeding treatment devices market size has shown strong growth recently. It is anticipated to expand from $0.92 billion in 2025 to $1 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.7%. This historic expansion can be linked to an increasing occurrence of gastrointestinal disorders, a rise in the prevalence of peptic ulcer disease, the broadening of endoscopic diagnostic procedures, a growth in hospital-based GI interventions, and the wider availability of advanced endoscopy equipment.

    The gastrointestinal bleeding treatment devices market size is projected to experience substantial expansion in the coming years, expected to reach $1.39 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.6%. This anticipated growth during the forecast period is driven by the increasing integration of next-generation endoscopic devices, a rising demand for outpatient GI procedures, a greater focus on early bleeding detection, the expansion of ambulatory surgical centers, and increasing investments in advanced GI care technologies. Prominent trends observed in the forecast period include the growing adoption of advanced endoscopic hemostasis devices, an increase in the use of minimally invasive GI bleeding treatments, escalating demand for precision thermal ablation tools, the expansion of mechanical hemostatic solutions, and an enhanced focus on rapid bleeding control technologies.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp

    What Primary Factors Are Fueling The Expansion Of The Gastrointestinal Bleeding Treatment Devices Market?

    The escalating prevalence of gastrointestinal disorders is predicted to significantly enhance market profitability. These conditions are often triggered by factors such as a low fiber diet, chronic stress, insufficient water intake, high consumption of dairy foods, an inactive lifestyle, aging, and genetic predispositions. For example, in October 2024, the National Library of Medicine, a US-based national library, reported, based on 2023 data, that 825 per 100,000 Canadians suffer from inflammatory bowel disease (IBD), affecting over 320,000 individuals. Projections indicate that this figure could reach 1.1% of the population, or around 470,000 Canadians, by 2035. Therefore, the increasing incidence of GI tract-related disorders is a key market driver.

    How Does Segment Analysis Break Down The Gastrointestinal Bleeding Treatment Devices Market Structure?

    The gastrointestinal bleeding treatment devices market covered in this report is segmented –

    1) By Product: Endoscopic Thermal Hemostasis Devices, Mechanical Hemostasis Devices, Injection-Based Hemostasis Devices, Topical Hemostatic Agents & Powders, Combination Or Multimodal Hemostasis Devices

    2) By GI Tract Division: Upper GI Tract, Lower GI Tract

    3) By End User: Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users

    Subsegments:

    1) By Endoscopic Thermal Hemostasis Devices: Electrocautery And Electrosurgical Coagulation Devices, Argon Plasma Coagulation (APC) Devices, Radiofrequency Ablation (RFA) Devices, Laser Coagulation Devices, Heater Probe Devices

    2) By Mechanical Hemostasis Devices: Hemostatic Clips (Through-the-Scope And Over-the-Scope Clips), Endoscopic Band Ligation Devices, Endoscopic Suturing Devices, Compression And Tamponade Devices

    3) By Injection-Based Hemostasis Devices: Epinephrine Injection Systems, Sclerosant Injection Devices, Cyanoacrylate Glue Injection Devices, Saline And Combination Injection Systems

    4) By Topical Hemostatic Agents And Powders: Hemostatic Powder Sprays, Absorbable Hemostatic Agents, Fibrin-Based Sealants, Collagen-Based Hemostatic Agents

    5) By Combination And Multimodal Hemostasis Devices: Thermal And Mechanical Combination Systems, Injection And Mechanical Combination Systems, Integrated Multimodal Endoscopic Hemostasis Platforms

    What Trends Are Affecting The Gastrointestinal Bleeding Treatment Devices Market Dynamics?

    Leading companies within the gastrointestinal bleeding treatment devices market are concentrating on developing advanced solutions, such as Hemospray, to enhance the effectiveness of treating acute bleeding in the GI tract. Hemospray functions as a hemostatic powder engineered to manage and control active GI bleeding. For instance, AIG Hospitals, based in India, launched Hemospray in January 2024, marking a significant advancement in controlling GI bleeding. This hemostatic agent is specifically formulated for use in endoscopic procedures to address acute gastrointestinal bleeding. Hemospray is particularly recognized for its ease of use, strong safety profile, and capacity to control a wide array of GI bleeds, ranging from peptic ulcers to variceal hemorrhages.

    Who Are The Leading Firms Participating In The Gastrointestinal Bleeding Treatment Devices Market?

    Major companies operating in the gastrointestinal bleeding treatment devices market are CONMED Corporation, Boston Scientific Corporation, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris plc, Medtronic plc, Johnson & Johnson, Abbott Laboratories, Fujifilm Holdings Corporation, Pentax Medical, Merit Medical Systems, Teleflex Incorporated, AngioDynamics, BTG International Ltd., Smiths Medical, Terumo Corporation, Nipro Corporation, C. R. Bard Inc., EndoChoice Holdings Inc., GI Supply Inc., Hemostasis LLC

    Access The Complete Gastrointestinal Bleeding Treatment Devices Market Report:

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

    Which Regional Market Leads The Gastrointestinal Bleeding Treatment Devices Market?

    North America was the largest region in the gastrointestinal bleeding treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal bleeding treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Access a Gastrointestinal Bleeding Treatment Devices Market Report for Deeper Competitive Insights

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

    Browse Through More Reports Similar to the Global Gastrointestinal Bleeding Treatment Devices Market 2026, By The Business Research Company

    Bleeding Disorders Treatment Market Report 2026

    https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report

    Gastrointestinal Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report

    Bleeding Disorder Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/bleeding-disorder-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Gastrointestinal Bleeding Treatment Devices Market Expansion Forecast Reaching $1.39 Billion By 2030 At 8.6% CAGR

    Gastrointestinal Bleeding Treatment Devices Market Expansion Forecast Reaching $1.39 Billion By 2030 At 8.6% CAGR

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    By 2030, What Market Size Is The Gastrointestinal Bleeding Treatment Devices Market Expected To Reach Based On Its 2026 Value?

    The gastrointestinal bleeding treatment devices market has seen significant expansion in recent years. It is anticipated to increase from $0.92 billion in 2025 to $1 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.7%. The expansion observed in prior periods can be attributed to a rising occurrence of gastrointestinal disorders, an increasing prevalence of peptic ulcer disease, the growth of endoscopic diagnostic procedures, an uptick in hospital-based GI interventions, and the availability of sophisticated endoscopy equipment.

    The gastrointestinal bleeding treatment devices market is anticipated to experience substantial growth in the upcoming years, with its valuation expected to reach $1.39 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.6%. This expansion during the forecast period is driven by factors such as the increasing adoption of next-generation endoscopic devices, a rising demand for outpatient GI procedures, a growing focus on early bleeding detection, the continued expansion of ambulatory surgical centers, and increased investments in advanced GI care technologies. Key trends influencing this period include the increasing adoption of advanced endoscopic hemostasis devices, a rising use of minimally invasive GI bleeding treatments, a growing demand for precision thermal ablation tools, the expansion of mechanical hemostatic solutions, and an enhanced focus on rapid bleeding control technologies.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp

    Which Major Drivers Are Influencing The Expansion Of The Gastrointestinal Bleeding Treatment Devices Market?

    The growing prevalence of gastrointestinal disorders is anticipated to significantly boost market profitability. These conditions often stem from various factors, including an insufficient fiber diet, stress, inadequate hydration, high dairy consumption, a sedentary lifestyle, advancing age, and genetic predispositions. A notable example comes from a 2023 report by the National Library of Medicine, a US-based national library (as cited in October 2024), which stated that 825 per 100,000 Canadians are affected by inflammatory bowel disease (IBD), totaling over 320,000 individuals. Furthermore, projections suggest this figure could escalate to 1.1% of the population, equating to around 470,000 Canadians, by 2035. Consequently, the rising occurrence of conditions impacting the GI tract is a significant market driver.

    How Are Different Segments Classified In The Gastrointestinal Bleeding Treatment Devices Market Segment Analysis?

    The gastrointestinal bleeding treatment devices market covered in this report is segmented –

    1) By Product: Endoscopic Thermal Hemostasis Devices, Mechanical Hemostasis Devices, Injection-Based Hemostasis Devices, Topical Hemostatic Agents & Powders, Combination Or Multimodal Hemostasis Devices

    2) By GI Tract Division: Upper GI Tract, Lower GI Tract

    3) By End User: Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users

    Subsegments:

    1) By Endoscopic Thermal Hemostasis Devices: Electrocautery And Electrosurgical Coagulation Devices, Argon Plasma Coagulation (APC) Devices, Radiofrequency Ablation (RFA) Devices, Laser Coagulation Devices, Heater Probe Devices

    2) By Mechanical Hemostasis Devices: Hemostatic Clips (Through-the-Scope And Over-the-Scope Clips), Endoscopic Band Ligation Devices, Endoscopic Suturing Devices, Compression And Tamponade Devices

    3) By Injection-Based Hemostasis Devices: Epinephrine Injection Systems, Sclerosant Injection Devices, Cyanoacrylate Glue Injection Devices, Saline And Combination Injection Systems

    4) By Topical Hemostatic Agents And Powders: Hemostatic Powder Sprays, Absorbable Hemostatic Agents, Fibrin-Based Sealants, Collagen-Based Hemostatic Agents

    5) By Combination And Multimodal Hemostasis Devices: Thermal And Mechanical Combination Systems, Injection And Mechanical Combination Systems, Integrated Multimodal Endoscopic Hemostasis Platforms

    Which Trends Are Shaping The Gastrointestinal Bleeding Treatment Devices Market?

    Major companies operating in the gastrointestinal bleeding treatment devices market are focusing on the development of advanced solutions, such as Hemospray, to improve the effectiveness of treating acute bleeding in the GI tract. Hemospray is a hemostatic powder designed to manage and control active bleeding within the gastrointestinal tract. For instance, in January 2024, AIG Hospitals, an India-based hospital, introduced Hemospray, representing a significant breakthrough in controlling GI bleeding. This hemostatic agent is specifically engineered for use in endoscopic procedures to manage acute gastrointestinal bleeding. Hemospray is notable for its ease of use, strong safety profile, and its capability to control a wide range of GI bleeds, from peptic ulcers to variceal hemorrhages.

    Who Are The Companies Driving Activity In The Gastrointestinal Bleeding Treatment Devices Market?

    Major companies operating in the gastrointestinal bleeding treatment devices market are CONMED Corporation, Boston Scientific Corporation, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris plc, Medtronic plc, Johnson & Johnson, Abbott Laboratories, Fujifilm Holdings Corporation, Pentax Medical, Merit Medical Systems, Teleflex Incorporated, AngioDynamics, BTG International Ltd., Smiths Medical, Terumo Corporation, Nipro Corporation, C. R. Bard Inc., EndoChoice Holdings Inc., GI Supply Inc., Hemostasis LLC

    Get The Full Gastrointestinal Bleeding Treatment Devices Market Report:

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

    Which Region Holds The Highest Market Share In The Gastrointestinal Bleeding Treatment Devices Market?

    North America was the largest region in the gastrointestinal bleeding treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal bleeding treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Gastrointestinal Bleeding Treatment Devices Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/customise?id=5307&type=smp

    Browse Through More Reports Similar to the Global Gastrointestinal Bleeding Treatment Devices Market 2026, By The Business Research Company

    Bleeding Disorders Treatment Market Report 2026

    https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report

    Gastrointestinal Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report

    Bleeding Disorder Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/bleeding-disorder-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Gastrointestinal Bleeding Treatment Devices Market Expansion Forecast Reaching $1.39 Billion By 2030 At 8.6% CAGR

    Gastrointestinal Bleeding Treatment Devices Market Expansion Forecast Reaching $1.39 Billion By 2030 At 8.6% CAGR

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    By 2030, What Market Size Is The Gastrointestinal Bleeding Treatment Devices Market Expected To Reach Based On Its 2026 Value?

    The gastrointestinal bleeding treatment devices market has seen significant expansion in recent years. It is anticipated to increase from $0.92 billion in 2025 to $1 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.7%. The expansion observed in prior periods can be attributed to a rising occurrence of gastrointestinal disorders, an increasing prevalence of peptic ulcer disease, the growth of endoscopic diagnostic procedures, an uptick in hospital-based GI interventions, and the availability of sophisticated endoscopy equipment.

    The gastrointestinal bleeding treatment devices market is anticipated to experience substantial growth in the upcoming years, with its valuation expected to reach $1.39 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.6%. This expansion during the forecast period is driven by factors such as the increasing adoption of next-generation endoscopic devices, a rising demand for outpatient GI procedures, a growing focus on early bleeding detection, the continued expansion of ambulatory surgical centers, and increased investments in advanced GI care technologies. Key trends influencing this period include the increasing adoption of advanced endoscopic hemostasis devices, a rising use of minimally invasive GI bleeding treatments, a growing demand for precision thermal ablation tools, the expansion of mechanical hemostatic solutions, and an enhanced focus on rapid bleeding control technologies.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp

    Which Major Drivers Are Influencing The Expansion Of The Gastrointestinal Bleeding Treatment Devices Market?

    The growing prevalence of gastrointestinal disorders is anticipated to significantly boost market profitability. These conditions often stem from various factors, including an insufficient fiber diet, stress, inadequate hydration, high dairy consumption, a sedentary lifestyle, advancing age, and genetic predispositions. A notable example comes from a 2023 report by the National Library of Medicine, a US-based national library (as cited in October 2024), which stated that 825 per 100,000 Canadians are affected by inflammatory bowel disease (IBD), totaling over 320,000 individuals. Furthermore, projections suggest this figure could escalate to 1.1% of the population, equating to around 470,000 Canadians, by 2035. Consequently, the rising occurrence of conditions impacting the GI tract is a significant market driver.

    How Are Different Segments Classified In The Gastrointestinal Bleeding Treatment Devices Market Segment Analysis?

    The gastrointestinal bleeding treatment devices market covered in this report is segmented –

    1) By Product: Endoscopic Thermal Hemostasis Devices, Mechanical Hemostasis Devices, Injection-Based Hemostasis Devices, Topical Hemostatic Agents & Powders, Combination Or Multimodal Hemostasis Devices

    2) By GI Tract Division: Upper GI Tract, Lower GI Tract

    3) By End User: Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users

    Subsegments:

    1) By Endoscopic Thermal Hemostasis Devices: Electrocautery And Electrosurgical Coagulation Devices, Argon Plasma Coagulation (APC) Devices, Radiofrequency Ablation (RFA) Devices, Laser Coagulation Devices, Heater Probe Devices

    2) By Mechanical Hemostasis Devices: Hemostatic Clips (Through-the-Scope And Over-the-Scope Clips), Endoscopic Band Ligation Devices, Endoscopic Suturing Devices, Compression And Tamponade Devices

    3) By Injection-Based Hemostasis Devices: Epinephrine Injection Systems, Sclerosant Injection Devices, Cyanoacrylate Glue Injection Devices, Saline And Combination Injection Systems

    4) By Topical Hemostatic Agents And Powders: Hemostatic Powder Sprays, Absorbable Hemostatic Agents, Fibrin-Based Sealants, Collagen-Based Hemostatic Agents

    5) By Combination And Multimodal Hemostasis Devices: Thermal And Mechanical Combination Systems, Injection And Mechanical Combination Systems, Integrated Multimodal Endoscopic Hemostasis Platforms

    Which Trends Are Shaping The Gastrointestinal Bleeding Treatment Devices Market?

    Major companies operating in the gastrointestinal bleeding treatment devices market are focusing on the development of advanced solutions, such as Hemospray, to improve the effectiveness of treating acute bleeding in the GI tract. Hemospray is a hemostatic powder designed to manage and control active bleeding within the gastrointestinal tract. For instance, in January 2024, AIG Hospitals, an India-based hospital, introduced Hemospray, representing a significant breakthrough in controlling GI bleeding. This hemostatic agent is specifically engineered for use in endoscopic procedures to manage acute gastrointestinal bleeding. Hemospray is notable for its ease of use, strong safety profile, and its capability to control a wide range of GI bleeds, from peptic ulcers to variceal hemorrhages.

    Who Are The Companies Driving Activity In The Gastrointestinal Bleeding Treatment Devices Market?

    Major companies operating in the gastrointestinal bleeding treatment devices market are CONMED Corporation, Boston Scientific Corporation, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris plc, Medtronic plc, Johnson & Johnson, Abbott Laboratories, Fujifilm Holdings Corporation, Pentax Medical, Merit Medical Systems, Teleflex Incorporated, AngioDynamics, BTG International Ltd., Smiths Medical, Terumo Corporation, Nipro Corporation, C. R. Bard Inc., EndoChoice Holdings Inc., GI Supply Inc., Hemostasis LLC

    Get The Full Gastrointestinal Bleeding Treatment Devices Market Report:

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

    Which Region Holds The Highest Market Share In The Gastrointestinal Bleeding Treatment Devices Market?

    North America was the largest region in the gastrointestinal bleeding treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal bleeding treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Gastrointestinal Bleeding Treatment Devices Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/customise?id=5307&type=smp

    Browse Through More Reports Similar to the Global Gastrointestinal Bleeding Treatment Devices Market 2026, By The Business Research Company

    Bleeding Disorders Treatment Market Report 2026

    https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report

    Gastrointestinal Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report

    Bleeding Disorder Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/bleeding-disorder-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Gastrointestinal Bleeding Treatment Devices Market Expansion Forecast Reaching $1.39 Billion By 2030 At 8.6% CAGR

    Gastrointestinal Bleeding Treatment Devices Market Expansion Forecast Reaching $1.39 Billion By 2030 At 8.6% CAGR

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    By 2030, What Market Size Is The Gastrointestinal Bleeding Treatment Devices Market Expected To Reach Based On Its 2026 Value?

    The gastrointestinal bleeding treatment devices market has seen significant expansion in recent years. It is anticipated to increase from $0.92 billion in 2025 to $1 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.7%. The expansion observed in prior periods can be attributed to a rising occurrence of gastrointestinal disorders, an increasing prevalence of peptic ulcer disease, the growth of endoscopic diagnostic procedures, an uptick in hospital-based GI interventions, and the availability of sophisticated endoscopy equipment.

    The gastrointestinal bleeding treatment devices market is anticipated to experience substantial growth in the upcoming years, with its valuation expected to reach $1.39 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.6%. This expansion during the forecast period is driven by factors such as the increasing adoption of next-generation endoscopic devices, a rising demand for outpatient GI procedures, a growing focus on early bleeding detection, the continued expansion of ambulatory surgical centers, and increased investments in advanced GI care technologies. Key trends influencing this period include the increasing adoption of advanced endoscopic hemostasis devices, a rising use of minimally invasive GI bleeding treatments, a growing demand for precision thermal ablation tools, the expansion of mechanical hemostatic solutions, and an enhanced focus on rapid bleeding control technologies.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp

    Which Major Drivers Are Influencing The Expansion Of The Gastrointestinal Bleeding Treatment Devices Market?

    The growing prevalence of gastrointestinal disorders is anticipated to significantly boost market profitability. These conditions often stem from various factors, including an insufficient fiber diet, stress, inadequate hydration, high dairy consumption, a sedentary lifestyle, advancing age, and genetic predispositions. A notable example comes from a 2023 report by the National Library of Medicine, a US-based national library (as cited in October 2024), which stated that 825 per 100,000 Canadians are affected by inflammatory bowel disease (IBD), totaling over 320,000 individuals. Furthermore, projections suggest this figure could escalate to 1.1% of the population, equating to around 470,000 Canadians, by 2035. Consequently, the rising occurrence of conditions impacting the GI tract is a significant market driver.

    How Are Different Segments Classified In The Gastrointestinal Bleeding Treatment Devices Market Segment Analysis?

    The gastrointestinal bleeding treatment devices market covered in this report is segmented –

    1) By Product: Endoscopic Thermal Hemostasis Devices, Mechanical Hemostasis Devices, Injection-Based Hemostasis Devices, Topical Hemostatic Agents & Powders, Combination Or Multimodal Hemostasis Devices

    2) By GI Tract Division: Upper GI Tract, Lower GI Tract

    3) By End User: Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users

    Subsegments:

    1) By Endoscopic Thermal Hemostasis Devices: Electrocautery And Electrosurgical Coagulation Devices, Argon Plasma Coagulation (APC) Devices, Radiofrequency Ablation (RFA) Devices, Laser Coagulation Devices, Heater Probe Devices

    2) By Mechanical Hemostasis Devices: Hemostatic Clips (Through-the-Scope And Over-the-Scope Clips), Endoscopic Band Ligation Devices, Endoscopic Suturing Devices, Compression And Tamponade Devices

    3) By Injection-Based Hemostasis Devices: Epinephrine Injection Systems, Sclerosant Injection Devices, Cyanoacrylate Glue Injection Devices, Saline And Combination Injection Systems

    4) By Topical Hemostatic Agents And Powders: Hemostatic Powder Sprays, Absorbable Hemostatic Agents, Fibrin-Based Sealants, Collagen-Based Hemostatic Agents

    5) By Combination And Multimodal Hemostasis Devices: Thermal And Mechanical Combination Systems, Injection And Mechanical Combination Systems, Integrated Multimodal Endoscopic Hemostasis Platforms

    Which Trends Are Shaping The Gastrointestinal Bleeding Treatment Devices Market?

    Major companies operating in the gastrointestinal bleeding treatment devices market are focusing on the development of advanced solutions, such as Hemospray, to improve the effectiveness of treating acute bleeding in the GI tract. Hemospray is a hemostatic powder designed to manage and control active bleeding within the gastrointestinal tract. For instance, in January 2024, AIG Hospitals, an India-based hospital, introduced Hemospray, representing a significant breakthrough in controlling GI bleeding. This hemostatic agent is specifically engineered for use in endoscopic procedures to manage acute gastrointestinal bleeding. Hemospray is notable for its ease of use, strong safety profile, and its capability to control a wide range of GI bleeds, from peptic ulcers to variceal hemorrhages.

    Who Are The Companies Driving Activity In The Gastrointestinal Bleeding Treatment Devices Market?

    Major companies operating in the gastrointestinal bleeding treatment devices market are CONMED Corporation, Boston Scientific Corporation, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris plc, Medtronic plc, Johnson & Johnson, Abbott Laboratories, Fujifilm Holdings Corporation, Pentax Medical, Merit Medical Systems, Teleflex Incorporated, AngioDynamics, BTG International Ltd., Smiths Medical, Terumo Corporation, Nipro Corporation, C. R. Bard Inc., EndoChoice Holdings Inc., GI Supply Inc., Hemostasis LLC

    Get The Full Gastrointestinal Bleeding Treatment Devices Market Report:

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

    Which Region Holds The Highest Market Share In The Gastrointestinal Bleeding Treatment Devices Market?

    North America was the largest region in the gastrointestinal bleeding treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal bleeding treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Gastrointestinal Bleeding Treatment Devices Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/customise?id=5307&type=smp

    Browse Through More Reports Similar to the Global Gastrointestinal Bleeding Treatment Devices Market 2026, By The Business Research Company

    Bleeding Disorders Treatment Market Report 2026

    https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report

    Gastrointestinal Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report

    Bleeding Disorder Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/bleeding-disorder-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Gastrointestinal Bleeding Treatment Devices Market 2026–2030: Emerging Trends and Forecast Opportunities

    Gastrointestinal Bleeding Treatment Devices Market 2026–2030: Emerging Trends and Forecast Opportunities

    Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

    Across 2026–2030, what is the expected market valuation path of the Gastrointestinal Bleeding Treatment Devices Market?

    The market size for gastrointestinal bleeding treatment devices has experienced robust expansion in recent years. This market is projected to expand from $0.92 billion in 2025 to $1 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.7%. Historically, this growth has been driven by factors such as the increasing occurrence of gastrointestinal disorders, the rising prevalence of peptic ulcer disease, the proliferation of endoscopic diagnostic procedures, the surge in hospital-based GI interventions, and the accessibility of sophisticated endoscopy equipment.

    The market for gastrointestinal bleeding treatment devices is projected to experience substantial expansion in the coming years, anticipated to reach $1.39 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.6%. This growth during the forecast period is fueled by several factors, including the increasing integration of next-generation endoscopic devices, the rising need for outpatient GI procedures, an intensifying focus on detecting bleeding early, the expansion of ambulatory surgical centers, and growing investments in sophisticated GI care technologies. Key trends defining this period encompass the wider adoption of advanced endoscopic hemostasis devices, an increase in the utilization of minimally invasive GI bleeding treatments, a surging demand for precision thermal ablation tools, the proliferation of mechanical hemostatic solutions, and a heightened emphasis on technologies for rapid bleeding control.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp

    Which Drivers Are Supporting The Rise Of The Gastrointestinal Bleeding Treatment Devices Market?

    The growing occurrence of gastrointestinal disorders is projected to enhance the market’s profitability. Factors such as an insufficient fiber intake, stress, inadequate hydration, excessive consumption of dairy products, a sedentary lifestyle, advancing age, and genetic predispositions can lead to gastrointestinal diseases. As an illustration, in October 2024, data from the National Library of Medicine, a US-based national library, indicated that in 2023, 825 per 100,000 Canadians were afflicted with inflammatory bowel disease (IBD), impacting over 320,000 individuals. Furthermore, forecasts suggest this figure might escalate to 1.1% of the population, which translates to approximately 470,000 Canadians, by 2035. Consequently, the rising incidence of disorders associated with the GI tract is propelling market expansion.

    What Segments Are Identified Within The Structure Of The Gastrointestinal Bleeding Treatment Devices Market?

    The gastrointestinal bleeding treatment devices market covered in this report is segmented –

    1) By Product: Endoscopic Thermal Hemostasis Devices, Mechanical Hemostasis Devices, Injection-Based Hemostasis Devices, Topical Hemostatic Agents & Powders, Combination Or Multimodal Hemostasis Devices

    2) By GI Tract Division: Upper GI Tract, Lower GI Tract

    3) By End User: Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users

    Subsegments:

    1) By Endoscopic Thermal Hemostasis Devices: Electrocautery And Electrosurgical Coagulation Devices, Argon Plasma Coagulation (APC) Devices, Radiofrequency Ablation (RFA) Devices, Laser Coagulation Devices, Heater Probe Devices

    2) By Mechanical Hemostasis Devices: Hemostatic Clips (Through-the-Scope And Over-the-Scope Clips), Endoscopic Band Ligation Devices, Endoscopic Suturing Devices, Compression And Tamponade Devices

    3) By Injection-Based Hemostasis Devices: Epinephrine Injection Systems, Sclerosant Injection Devices, Cyanoacrylate Glue Injection Devices, Saline And Combination Injection Systems

    4) By Topical Hemostatic Agents And Powders: Hemostatic Powder Sprays, Absorbable Hemostatic Agents, Fibrin-Based Sealants, Collagen-Based Hemostatic Agents

    5) By Combination And Multimodal Hemostasis Devices: Thermal And Mechanical Combination Systems, Injection And Mechanical Combination Systems, Integrated Multimodal Endoscopic Hemostasis Platforms

    Which Market Trends Are Opening Growth Opportunities In The Gastrointestinal Bleeding Treatment Devices Market?

    Major companies operating in the gastrointestinal bleeding treatment devices market are concentrating on developing advanced solutions, such as Hemospray, to improve the effectiveness of treating acute bleeding in the gastrointestinal (GI) tract. Hemospray functions as a hemostatic powder specifically designed to manage and control active bleeding within the GI tract. For instance, in January 2024, AIG Hospitals, an India-based hospital, introduced Hemospray, which represents a significant breakthrough in controlling GI bleeding. This hemostatic agent is specifically formulated for use in endoscopic procedures to control acute gastrointestinal (GI) bleeding. Hemospray is recognized for its ease of use, strong safety profile, and its capability to manage a wide range of GI bleeds, from conditions like peptic ulcers to variceal hemorrhages.

    Which Leading Companies Dominate The Gastrointestinal Bleeding Treatment Devices Market Share?

    Major companies operating in the gastrointestinal bleeding treatment devices market are CONMED Corporation, Boston Scientific Corporation, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris plc, Medtronic plc, Johnson & Johnson, Abbott Laboratories, Fujifilm Holdings Corporation, Pentax Medical, Merit Medical Systems, Teleflex Incorporated, AngioDynamics, BTG International Ltd., Smiths Medical, Terumo Corporation, Nipro Corporation, C. R. Bard Inc., EndoChoice Holdings Inc., GI Supply Inc., Hemostasis LLC

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

    How Does The Gastrointestinal Bleeding Treatment Devices Market Perform Across Major Global Regions?

    North America was the largest region in the gastrointestinal bleeding treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal bleeding treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Gastrointestinal Bleeding Treatment Devices Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=5307&type=smp

    Browse Through More Reports Similar to the Global Gastrointestinal Bleeding Treatment Devices Market 2026, By The Business Research Company

    Bleeding Disorders Treatment Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report

    Gastrointestinal Devices Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report

    Bleeding Disorder Testing Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/bleeding-disorder-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

  • Gastrointestinal Bleeding Treatment Devices Market Outlook 2025–2029: Emerging Opportunities and Key Drivers

    Gastrointestinal Bleeding Treatment Devices Market Outlook 2025–2029: Emerging Opportunities and Key Drivers

    Uncover key drivers, emerging technologies, and competitive movements shaping the gastrointestinal bleeding treatment devices market from 2025–2034 with trusted insights from The Business Research Company

    What Is The Present Size Of The Gastrointestinal Bleeding Treatment Devices Market And What Value Is Projected For 2029?

    The gastrointestinal bleeding treatment devices market size has shown robust growth in recent years. It is anticipated to increase from $0.87 billion in 2024 to $0.92 billion in 2025, progressing at a compound annual growth rate (CAGR) of 5.3%. The expansion observed in the past can be ascribed to an aging population, lifestyle factors, developments in healthcare infrastructure, the occurrence of gastrointestinal disorders, and advancements in endoscopy.

    The gastrointestinal bleeding treatment devices market is poised for substantial expansion over the coming years. This market is forecasted to attain a value of $1.28 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 8.7%. This expansion throughout the prediction period is propelled by factors such as patient-centric care initiatives, evolving regulatory frameworks, the adoption of telemedicine and remote consultations, a rise in gastrointestinal disorders, and increased healthcare investment. Prominent trends anticipated in this period encompass non-invasive diagnostic technologies, precision medicine approaches, remote monitoring and telehealth solutions, and the application of artificial intelligence and machine learning.

    Access A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp

    What Factors Are Boosting The Gastrointestinal Bleeding Treatment Devices Market?

    The increasing occurrence of upper gastrointestinal bleeding is expected to fuel the expansion of the gastrointestinal bleeding treatment devices market throughout the projected timeframe. Upper gastrointestinal (GI) bleeding manifests in the esophagus, stomach, or the initial segment of the small intestine, potentially stemming from conditions such as peptic ulcers, esophagitis, enteritis, gastritis, cancer, among other factors. As an illustration, data from the National Institute for Health and Care Excellence indicates that in the UK, the annual incidence of acute upper GI bleeding varies between 84-172 per 100,000 individuals. Moreover, a study published in the National Library of Medicine – National Institutes of Health in 2023 reported that in-hospital mortality rates for upper GI bleeds are approximately 10%. This percentage holds steady for up to one month post-hospitalization for GI bleed. In the long run, three years subsequent to admission, overall mortality rates approach almost 37%.

    What Are The Core Segmentation Criteria In The Gastrointestinal Bleeding Treatment Devices Market?

    The gastrointestinal bleeding treatment devicesmarket covered in this report is segmented –

    1) By Product: Endoscopic Thermal Devices, Other Products

    2) By GI Tract Division: Upper GI Tract, Lower GI Tract

    3) By End User: Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users

    Subsegments:

    1) By Endoscopic Thermal Devices: Radiofrequency Ablation Devices, Laser Therapy Devices, Coagulation Devices

    2) By Other Products: Hemostatic Clips, Injection Devices, Mechanical Hemostatic Devices

    Which Emerging Trends Are Reshaping The Gastrointestinal Bleeding Treatment Devices Market Landscape?

    Leading companies in the gastrointestinal bleeding treatment devices market are prioritizing the development of sophisticated solutions, such as the EVIS X1 endoscopy system, to heighten diagnostic accuracy, improve patient outcomes, and streamline clinical operations. The EVIS X1 endoscopy system is a state-of-the-art endoscopic imaging platform engineered to elevate diagnostic precision and therapeutic interventions across various medical fields, including gastroenterology, pulmonology, and urology. For instance, in November 2023, Olympus Corporation, a Japan-based provider of medical and surgical technologies, unveiled its advanced next-generation EVIS X1 endoscopy system. This next-generation EVIS X1 endoscopy system marks a significant advancement in endoscopic imaging technology, designed to boost diagnostic capabilities, enhance procedural efficiency, and facilitate improved clinical results. This latest version of the EVIS X1 expands upon its predecessor by incorporating advanced imaging techniques, intuitive user interfaces, and artificial intelligence (AI) support, tailored for a broad spectrum of medical applications, particularly in gastroenterology and pulmonology.

    Which Players Are Shaping The Competitive Landscape Of The Gastrointestinal Bleeding Treatment DevicesXX Market?

    Major companies operating in the gastrointestinal bleeding treatment devices market include CONMED Corporation, Boston Scientific Corporation, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris plc., Medtronic, Johnson & Johnson, Abbott Laboratories, Fujifilm Holdings Corporation, Pentax Medical, Merit Medical Systems, Teleflex Incorporated, AngioDynamics, BTG International Ltd., Medline Industries Inc. Smiths Medical, Terumo Corporation, Nipro Corporation, ConvaTec Group PLC, Coloplast A/S, Hollister Incorporated, Wellspect HealthCare, C. R. Bard Inc., EndoChoice Holdings Inc., GI Supply Inc., Hemostasis LLC

    Download The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

    What Regional Trends Are Shaping Growth In The Gastrointestinal Bleeding Treatment Devices Market?

    North America was the largest region in the gastrointestinal bleeding treatment devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal bleeding treatment devices market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    Get A Report Customized For You Here:

    https://www.thebusinessresearchcompany.com/customise?id=5307&type=smp

    Browse Through More Reports Similar to the Global Gastrointestinal Bleeding Treatment Devices Market 2025, By The Business Research Company

    Wearable Blood Pressure Monitors Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/wearable-blood-pressure-monitors-global-market-report

    Patient Blood Management Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report

    Conjugated Monoclonal Antibodie Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/conjugated-monoclonal-antibodie-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Gastrointestinal Bleeding Treatment Devices Market Size Projected to Reach $1.28 Billion During the Forecast Period

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    #What Is The Anticipated Size Of The Gastrointestinal Bleeding Treatment Devices Market Over The Five-Year Period 2025–2029?#_x000D_

    The market for devices utilized in treating gastrointestinal bleeding has experienced robust expansion recently, projected to increase from a value of $0.87 billion in 2024 to $0.92 billion the subsequent year, reflecting a compound annual growth rate of 5.3%; this upward trajectory over the historical duration is linked to several factors, including demographic shifts toward an older population, various lifestyle influences, improvements in medical facilities, the prevalence of gastrointestinal pathologies, and technological progress in endoscopic procedures._x000D_

    _x000D_

    Anticipation surrounds the gastrointestinal bleeding treatment devices market, forecasting considerable expansion ahead, with its valuation projected to reach $1.28 billion by 2029, driven by an 8.7% compound annual growth rate throughout the projection timeframe; this upward trajectory is fueled by several factors, notably the shift toward personalized patient care approaches, evolving regulatory landscapes, the integration of telemedicine for remote contact, a rise in instances of gastrointestinal ailments, and augmented spending within the healthcare sector; furthermore, key developments shaping this segment involve the advent of minimally invasive diagnostic tools, which are mentioned twice, the adoption of highly tailored medical treatments, and the growing incorporation of artificial intelligence and machine learning alongside remote monitoring capabilities._x000D_

    _x000D_

    #Unlock Your Free Sample Report for Exclusive Market Data:#_x000D_

    https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp_x000D_

    _x000D_

    #What Are The Top Growth Drivers Impacting The Gastrointestinal Bleeding Treatment Devices Market Outlook?#_x000D_

    The anticipated escalation in occurrences of bleeding within the upper sections of the digestive tract is poised to propel the expansion of the market for gastrointestinal bleeding management devices throughout the projection timeframe. This upper GI bleeding, which compromises the esophagus, stomach, or the initial segment of the small intestine, can stem from various conditions such as ulcers, inflammation of the esophagus or stomach lining, small intestine inflammation, malignancies, and other underlying issues. To illustrate the prevalence, data cited by the UK’s National Institute for Health and Care Excellence suggests that the annual incidence rate for sudden upper GI bleeding falls between 84 and 172 individuals out of every 100,000 people. Moreover, a 2023 investigation documented in the National Library of Medicine – National Institutes of Health indicated that in-facility death rates associated with upper GI hemorrhages hover around 10%, a figure that is sustained for the initial month post-admission for the bleeding episode; however, looking at the extended outcome, the overall mortality rate from any cause climbs to almost 37% three years after the initial hospitalization._x000D_

    _x000D_

    #How Is The Gastrointestinal Bleeding Treatment Devices Market Segmented? #_x000D_

    The gastrointestinal bleeding treatment devicesmarket covered in this report is segmented – _x000D_

    _x000D_

    1) By Product: Endoscopic Thermal Devices, Other Products_x000D_

    2) By GI Tract Division: Upper GI Tract, Lower GI Tract_x000D_

    3) By End User: Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users_x000D_

    _x000D_

    Subsegments:_x000D_

    1) By Endoscopic Thermal Devices: Radiofrequency Ablation Devices, Laser Therapy Devices, Coagulation Devices_x000D_

    2) By Other Products: Hemostatic Clips, Injection Devices, Mechanical Hemostatic Devices _x000D_

    _x000D_

    #Which Market Trends Are Creating New Opportunities In The Gastrointestinal Bleeding Treatment Devices Industry?#_x000D_

    Key players within the market for gastrointestinal bleeding treatment devices are dedicating efforts toward creating sophisticated offerings, exemplified by the EVIS X1 endoscopy system, which aims to boost the precision of diagnoses, elevate recovery for patients, and make clinical processes more efficient. This EVIS X1 endoscopy system constitutes a state-of-the-art platform for endoscopic imagery, engineered to refine the precision of identifying conditions and executing treatment procedures across diverse medical fields, such as those dealing with the digestive tract, lungs, and urinary system. As an illustration, in November of 2023, Olympus Corporation, a medical and surgical technology firm situated in Japan, introduced its sophisticated, forward-looking EVIS X1 endoscopy system. Representing a significant step forward in endoscopic visualization, this newer EVIS X1 endoscopy system has been developed to augment diagnostic potential, increase the effectiveness of procedures, and result in superior patient results; this updated version improves upon earlier models by integrating the newest imaging methods, interfaces that are simpler for users to navigate, and assistance derived from artificial intelligence, all customized to suit numerous medical uses, especially within gastroenterology and pulmonology._x000D_

    _x000D_

    #Which Major Firms Are Strengthening Their Position In The Gastrointestinal Bleeding Treatment Devices Industry?#_x000D_

    Major companies operating in the gastrointestinal bleeding treatment devices market include CONMED Corporation, Boston Scientific Corporation, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris plc., Medtronic, Johnson & Johnson, Abbott Laboratories, Fujifilm Holdings Corporation, Pentax Medical, Merit Medical Systems, Teleflex Incorporated, AngioDynamics, BTG International Ltd., Medline Industries Inc. Smiths Medical, Terumo Corporation, Nipro Corporation, ConvaTec Group PLC, Coloplast A/S, Hollister Incorporated, Wellspect HealthCare, C. R. Bard Inc., EndoChoice Holdings Inc., GI Supply Inc., Hemostasis LLC _x000D_

    _x000D_

    #Download The Full Report For Exclusive Market Findings:#_x000D_

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report_x000D_

    _x000D_

    #What Are The Regional Market Dynamics Impacting The Gastrointestinal Bleeding Treatment Devices Industry?#_x000D_

    North America was the largest region in the gastrointestinal bleeding treatment devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal bleeding treatment devices market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa._x000D_

    _x000D_

    #Request A Customized Version Of The Gastrointestinal Bleeding Treatment Devices Market Report:#_x000D_

    https://www.thebusinessresearchcompany.com/customise?id=5307&type=smp_x000D_

    _x000D_

    #Browse Through More Reports Similar to the Global Gastrointestinal Bleeding Treatment Devices Market 2025, By The Business Research Company#_x000D_

    _x000D_

    Wearable Blood Pressure Monitors Global Market Report 2025_x000D_

    https://www.thebusinessresearchcompany.com/report/wearable-blood-pressure-monitors-global-market-report_x000D_

    _x000D_

    Patient Blood Management Global Market Report 2025_x000D_

    https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report_x000D_

    _x000D_

    Conjugated Monoclonal Antibodie Global Market Report 2025_x000D_

    https://www.thebusinessresearchcompany.com/report/conjugated-monoclonal-antibodie-global-market-report_x000D_

    _x000D_

    #Get in touch with us:#_x000D_

    _x000D_

    The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

    Americas +1 310-496-7795_x000D_

    Asia +44 7882 955267 & +91 8897263534_x000D_

    Europe +44 7882 955267_x000D_

    Email us at info@tbrc.info_x000D_

    _x000D_

    #Follow us on:#_x000D_

    _x000D_

    LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Gastrointestinal Bleeding Treatment Devices Market Trends: Regional Breakdowns and Strategic Insights

    Global Gastrointestinal Bleeding Treatment Devices Market Trends: Regional Breakdowns and Strategic Insights

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    How Has The Gastrointestinal Bleeding Treatment Devices Market Size Shifted, And What Is the Outlook Through 2034?

    In recent times, there has been robust growth in the market size of devices used to treat gastrointestinal bleeding. The value will scale up from $0.87 billion in 2024 to $0.92 billion in 2025, showing a compound annual growth rate (CAGR) of 5.3%. The growth in the past can be accredited to factors such as an expanding elderly population, changing lifestyle patterns, developments in healthcare facilities, prevalence of gastrointestinal conditions, and advancements in endoscopy procedures.

    In the coming years, substantial growth is anticipated in the market size of gastrointestinal bleeding treatment devices. It’s predicted that the market will reach a value of $1.28 billion by 2029, progressing at a compound annual growth rate (CAGR) of 8.7%. This expected growth can be connected to several factors, such as patient-focused treatments, regulatory shifts, the use of telehealth and remote consultations, a rise in gastrointestinal disorders, and investments in healthcare. The market trends to watch in the forecast period involve non-invasive diagnostic technologies, precision medicine, remote monitoring with telehealth, and the application of artificial intelligence and machine learning.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp

    What Are the Major Market Drivers Behind the Rising Adoption of Gastrointestinal Bleeding Treatment Devices Market?

    Increased occurrences of bleeding in the upper gastrointestinal tract are expected to bolster the growth of the market for gastrointestinal bleeding treatment devices for the foreseeable future. Upper gastrointestinal bleeding, which can happen in the esophagus, stomach, or the first section of the small intestine, can be caused by a range of conditions such as peptic ulcers, esophagitis, gastritis, enteritis, cancer, among others. For example, data from the UK’s National Institute for Health and Care Excellence indicate that the incidence of severe upper GI bleeding is between 84-172 per 100,000 people annually. Moreover, research from the National Library of Medicine – National Institutes of Health stated in 2023 that the in-patient mortality rate for upper GI bleeds is around 10%. This statistic stays stable for a month after a GI bleed hospitalization. In the long-run, mortality rates from all causes surge to nearly 37%, three years after being admitted.

    Which Key Market Segments Comprise the Gastrointestinal Bleeding Treatment Devices Market and Drive Its Revenue Growth?

    The gastrointestinal bleeding treatment devicesmarket covered in this report is segmented –

    1) By Product: Endoscopic Thermal Devices, Other Products

    2) By GI Tract Division: Upper GI Tract, Lower GI Tract

    3) By End User: Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users

    Subsegments:

    1) By Endoscopic Thermal Devices: Radiofrequency Ablation Devices, Laser Therapy Devices, Coagulation Devices

    2) By Other Products: Hemostatic Clips, Injection Devices, Mechanical Hemostatic Devices

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=5307&type=smp

    Which Areas Are Leading Regions in the Gastrointestinal Bleeding Treatment Devices Market Expansion Across the Globe?

    North America was the largest region in the gastrointestinal bleeding treatment devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal bleeding treatment devices market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    What Are the Strategic Trends Steering theGastrointestinal Bleeding Treatment Devices Market Direction?

    In an attempt to bolster diagnostic accuracy, improve patient results, and simplify clinical operations, top businesses in the gastrointestinal hemorrhage treatment devices field are concentrating on creating advanced systems, such as the EVIS X1 endoscopy machine. This sophisticated endoscopic imaging framework, the EVIS X1 endoscopy system, is intended to enhance diagnostic correctness and therapeutic interventions in several medical disciplines, which include gastroenterology, pulmonology, and urology. For example, Olympus Corporation, a Japan-based medical and surgical technologies organization, introduced its advanced next-generation EVIS X1 endoscopy system in November 2023. This newest version of the EVIS X1 is an evolved revolution in endoscopic imaging technology, constructed to amplify diagnostic potential, maximize procedural productivity, and foster improved clinical outcomes. The updated EVIS X1 enhances its previous version by integrating innovative imaging techniques, user-friendly control panels, and artificial intelligence (AI) assistance, specifically designed to cater to a plethora of medical uses, majorly in gastroenterology and pulmonology.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

    How Is the Gastrointestinal Bleeding Treatment Devices Market Conceptually Defined?

    Gastrointestinal (GI) bleeding is a sign of an illness in which the gastrointestinal system bleeds. The bleeding could occur anywhere in the gastrointestinal system, including the large intestine, anus, esophagus, small intestine, rectum, and stomach.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5307

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Europe +44 7882 955267

    Asia & Others +44 7882 955267 & +91 8897263534

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Gastrointestinal Bleeding Treatment Devices Market Outlook 2025 – Insights for Executive and Strategic Planning

    Gastrointestinal Bleeding Treatment Devices Market Outlook 2025 – Insights for Executive and Strategic Planning

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    How Has the Gastrointestinal Bleeding Treatment Devices Market Grown from 2024 to 2025?

    The market for devices used in the treatment of gastrointestinal bleeding has seen significant expansion in the past few years. It is projected to increase from a size of $0.87 billion in 2024 to $0.93 billion in 2025, boasting a compound annual growth rate (CAGR) of 6.1%. This growth during the past period is a result of various factors including an aging population, lifestyle habits, development in healthcare facilities, prevalence of gastrointestinal diseases, and advancements in endoscopic procedures.

    What Growth Rate Is Anticipated for the Gastrointestinal Bleeding Treatment Devices Market in the Coming Years?

    The market for devices treating gastrointestinal bleeding is projected to experience robust growth in the near future, with the expectation of reaching a market value of $1.3 billion by 2029, at a Compound Annual Growth Rate (CAGR) of 8.9%. The projected growth in the forecast period can be linked to factors such as patient-focused treatments, regulatory alterations, advancements in telemedicine, and remote consultations, an increase in gastrointestinal disorders, and an uptick in healthcare investment. Notable trends anticipated during this period include non-invasive diagnostic technologies, precision medicine, remote patient monitoring and telehealth, as well as the integration of artificial intelligence and machine learning.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp

    Who Are the Leading Companies in the Gastrointestinal Bleeding Treatment Devices Market?

    Major companies operating in the gastrointestinal bleeding treatment devices market include CONMED Corporation, Boston Scientific Corporation, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris plc., Medtronic, Johnson & Johnson, Abbott Laboratories, Fujifilm Holdings Corporation, Pentax Medical, Merit Medical Systems, Teleflex Incorporated, AngioDynamics, BTG International Ltd., Medline Industries Inc. Smiths Medical, Terumo Corporation, Nipro Corporation, ConvaTec Group PLC, Coloplast A/S, Hollister Incorporated, Wellspect HealthCare, C. R. Bard Inc., EndoChoice Holdings Inc., GI Supply Inc., Hemostasis LLC

    What Are the Key Drivers of the Gastrointestinal Bleeding Treatment Devices Market?

    The increasing instances of upper gastrointestinal bleeding are expected to drive the growth of the market for gastrointestinal bleeding treatment devices in the coming years. Upper gastrointestinal (GI) bleeding takes place in the esophagus, stomach, or upper section of the small intestine and may be a result of various conditions such as peptic ulcers, esophagitis, enteritis, gastritis, cancer, among others. For example, the UK’s National Institute for Health and Care Excellence has noted that the annual rate of acute upper GI bleeding ranges from 84-172 for every 100,000 population. Additionally, research published in the National Library of Medicine – National Institutes of Health in 2023, says that in-hospital death rates for upper GI bleeds are approximately 10%. This figure remains constant for one month following hospitalization due to a GI bleed. Looking at the long term, mortality rates from all reasons rise to nearly 37% three years post-admission.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=5307&type=smp

    What Are the Key Market Segments in the Gastrointestinal Bleeding Treatment Devices Industry?

    The gastrointestinal bleeding treatment devices market covered in this report is segmented –

    1) By Product: Endoscopic Thermal Devices, Other Products

    2) By GI Tract Division: Upper GI Tract, Lower GI Tract

    3) By End User: Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users

    Subsegments:

    1) By Endoscopic Thermal Devices: Radiofrequency Ablation Devices, Laser Therapy Devices, Coagulation Devices

    2) By Other Products: Hemostatic Clips, Injection Devices, Mechanical Hemostatic Devices

    What Are the Latest Trends in the Gastrointestinal Bleeding Treatment Devices Market?

    Prominent companies within the gastrointestinal bleeding treatment devices market are concentrating on innovating advanced solutions, like the EVIS X1 endoscopy system, to augment diagnostic precision, increase the quality of patient results, and make clinical workflows more efficient. Specifically created to boost diagnostic accuracy and therapeutic treatments in various medical sectors, such as gastroenterology, pulmonology, and urology, the EVIS X1 endoscopy system represents a significant enhancement in endoscopic imaging technology. In November 2023, Olympus Corporation, a Japanese firm known for medical and surgical technologies, introduced its latest next-generation EVIS X1 endoscopy system. This new edition of EVIS X1 further develops its earlier concept by integrating pioneering imaging approaches, intuitive user interfaces, and the benefits of artificial intelligence (AI). This makes it a comprehensive solution for diverse medical uses, particularly in gastroenterology and pulmonology.

    Access The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

    What Are the Key Regional Markets in the Gastrointestinal Bleeding Treatment Devices Industry?

    North America was the largest region in the gastrointestinal bleeding treatment devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal bleeding treatment devices market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    Purchase The Full Report Today:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5307

    This Report Delivers Insight On:

    1. How big is the gastrointestinal bleeding treatment devices market, and how is it changing globally?

    2. Who are the major companies in the gastrointestinal bleeding treatment devices market, and how are they performing?

    3. What are the key opportunities and risks in the gastrointestinal bleeding treatment devices market right now?

    4. Which products or customer segments are growing the most in the gastrointestinal bleeding treatment devices market?

    5. What factors are helping or slowing down the growth of the gastrointestinal bleeding treatment devices market?

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model